Showing results (271-280 of 515) with videos related to

Sort By:
Pageof 52
Elife|August 23, 2017
The Calcineurin-FoxO-MuRF1 signaling pathway regulates myofibril integrity in cardiomyocytesHirohito Shimizu, Adam D Langenbacher, Jie Huang, et al.
Extremophiles : Life Under Extreme Conditions|June 10, 2017
Molecular cloning and expression analysis of major intrinsic protein gene in Chlamydomonas sp. ICE-L from AntarcticaLulu Li, Meiling An, Changfeng Qu, et al.
International Journal of Clinical Practice|September 1, 2016
Patient-related factors that influence coronary artery density in CCTA: a retrospective clinical studyPeng Cao, Miao He, Chen Qiao, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 24, 2025
Structurally-defined non-cationic docosahexaenoic acid based siRNA-micelles for safe and effective combinatorial glioblastoma therapySen Xu, Mengyu Fan, Qimeng Ding, et al.
Journal of Colloid and Interface Science|October 14, 2023
Facile synthesis of ultrafine iron-cobalt (FeCo) nanocrystallite-embedded boron/nitrogen-codoped porous carbon nanosheets: Accelerated water splitting catalystsLan Xiao, Yibin Wang, Tingzheng Fu, et al.
Cardiovascular Research|April 26, 2024
Serine protease inhibitor, SerpinA3n, regulates cardiac remodelling after myocardial infarctionQihao Sun, Wei Chen, Rimao Wu, et al.
Current Medical Research and Opinion|October 13, 2007
Evaluation of the potential for steady-state pharmacokinetic interaction between vildagliptin and simvastatin in healthy subjectsSurya P Ayalasomayajula, Kiran Dole, Yan-Ling He, et al.
The Journal of Cell Biology|October 6, 2005
Cholesterol-induced macrophage apoptosis requires ER stress pathways and engagement of the type A scavenger receptorTracie Devries-Seimon, Yankun Li, Pin Mei Yao, et al.
The Journal of Clinical Investigation|March 18, 2003
The role of the Grb2-p38 MAPK signaling pathway in cardiac hypertrophy and fibrosisShaosong Zhang, Carla Weinheimer, Michael Courtois, et al.
Biopharmaceutics & Drug Disposition|January 19, 2007
Oral-intravenous crossover study of fingolimod pharmacokinetics, lymphocyte responses and cardiac effectsJohn M Kovarik, Stefan Hartmann, Michael Bartlett, et al.
Pageof 52